Eli Lilly and Company

ZYPREXA RELPREVV

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Eli Lilly and Company

Zyprexa Relprevv HCPCS:

J2358

HCPCS Code Descriptor:

Injection, olanzapine, long-acting, 1 mg

Category:

J Code

Zyprexa Relprevv NDCs:

00002-7636-11, 00002-7635-11, 00002-7637-11

Primary Type:

Psychiatric

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intramuscular

Zyprexa Relprevv CPT Codes:

Potential CPT administration codes for Zyprexa Relprevv can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zyprexa Relprevv:

ZYPREXA RELPREVV is a Psychiatric drug manufactured by Eli Lilly and Company and administered via the Intramuscular route of administration. The J Code: J2358 is aligned to the drug ZYPREXA RELPREVV.

ACCESS PRICING AND MORE BY REGISTERING

J2358 Added Date:

January 1, 2011

J2358 Effective Date:

January 1, 2018

J2358 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zyprexa Relprevv billing and coding information.
Our team did not identify a source for Zyprexa Relprevv patient assistance information. Please reach out to our team if you feel that this is a mistake.
ZYPREXA RELPREVV prescribing information can be found at the link below:
Information regarding ZYPREXA RELPREVV’s side effects can be found at MedlinePlus